High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study

Despite the increasing evidence of the benefit of corticosteroids for the treatment of moderate-severe coronavirus disease 2019 (COVID-19) patients, no data are available about the potential role of high doses of steroids for these patients. We evaluated the mortality, the risk of need for mechanica...

Descripción completa

Detalles Bibliográficos
Autores principales: Monreal, Enric, Sainz de la Maza, Susana, Natera-Villalba, Elena, Beltrán-Corbellini, Álvaro, Rodríguez-Jorge, Fernando, Fernández-Velasco, Jose Ignacio, Walo-Delgado, Paulette, Muriel, Alfonso, Zamora, Javier, Alonso-Canovas, Araceli, Fortún, Jesús, Manzano, Luis, Montero-Errasquín, Beatriz, Costa-Frossard, Lucienne, Masjuan, Jaime, Villar, Luisa María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575217/
https://www.ncbi.nlm.nih.gov/pubmed/33083917
http://dx.doi.org/10.1007/s10096-020-04078-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575217/
https://www.ncbi.nlm.nih.gov/pubmed/33083917
http://dx.doi.org/10.1007/s10096-020-04078-1

Ejemplares similares